IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS - ANVISA Registration 80000230031
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230031 and manufactured by manufacturer not specified. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Apr 07, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including LEICA BIOSYSTEMS NEWCASTLE LTD, VENTANA MEDICAL SYSTEM, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80000230031
25351551536201614
03290250000100
Company Information
Dates and Status
Dec 26, 2016
07/04/2034
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS
FAMÍLIA DE MARCADORES DE CARCINOMA DE MAMA
AGILENT TECHNOLOGIES, INC.
80000230090
Oct 21, 2024
IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS
FAMÍLIA DE MARCADORES DE CARCINOMA DE MAMA
Not specified
80000230090
Oct 21, 2024
IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS
FAMÍLIA DE MARCADORES DE CARCINOMAS DE MAMA
Not specified
80358430002
Jul 26, 2010
IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS
FAMÍLIA DE MARCADORES DE CARCINOMAS DE MAMA
CELL MARQUE CORPORATION
80358430002
Jul 26, 2010
IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS
Familia Cancer de Mama
Not specified
10287410785
May 13, 2009
LEICA BIOSYSTEMS NEWCASTLE LTD• United Kingdom
VENTANA MEDICAL SYSTEM, INC• United States of America
AGILENT TECHNOLOGIES, INC.• United States of America
CELL MARQUE CORPORATION• United States of America
ROCHE DIAGNOSTICS GMBH• Germany
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE MAMA
FAMÍLIA DE MARCADORES DE CARCINOMA DE MAMA
Not specified
80000230090
Oct 21, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE MAMA
FAMÍLIA DE MARCADORES DE CARCINOMA DE MAMA
AGILENT TECHNOLOGIES, INC.
80000230090
Oct 21, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE MAMA
VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody
ROCHE DIAGNOSTICS GMBH
10287411687
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE MAMA
VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody
Not specified
10287411687
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE MAMA
Família Anticorpo para Detecção de Carcinoma de Mama Leica
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990036
Jul 02, 2018